Photo
September 6, 2009
Visiogen’s Synchrony lens: under FDA review
Stories this photo appears in:
Abbott Expands in Eye Market with Visiogen
HEALTHCARE: $400M buyout signals good trial results for lenses
Abbott Laboratories has bought Visiogen Inc. for $400 million
